» Articles » PMID: 20071760

Kinetic Filtering of [(18)F]Fluorothymidine in Positron Emission Tomography Studies

Overview
Journal Phys Med Biol
Publisher IOP Publishing
Date 2010 Jan 15
PMID 20071760
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

[(18)F]Fluorothymidine (FLT) is a cell proliferation marker that undergoes predominantly hepatic metabolism and therefore shows a high level of accumulation in the liver, as well as in rapidly proliferating tumours. Furthermore, the tracer's uptake is substantial in other organs including the heart. We present a nonlinear kinetic filtering technique which enhances the visualization of tumours imaged with FLT positron emission tomography (FLT-PET). A classification algorithm to isolate cancerous tissue from healthy organs was developed and validated using 29 scan data from patients with locally advanced or metastatic breast cancer. A large reduction in signal from the liver and heart of 80% was observed following application of the kinetic filter, whilst the majority of signal from both primary tumours and metastases was retained. A scan acquisition time of 60 min has been shown to be sufficient to obtain the necessary kinetic data. The algorithm extends utility of FLT-PET imaging in oncology research.

Citing Articles

Supervised clustering for TSPO PET imaging.

Schubert J, Tonietto M, Turkheimer F, Zanotti-Fregonara P, Veronese M Eur J Nucl Med Mol Imaging. 2021; 49(1):257-268.

PMID: 33779770 PMC: 8712290. DOI: 10.1007/s00259-021-05309-z.


Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using F-Fluorothymidine PET.

Sharma R, Inglese M, Dubash S, Lu H, Pinato D, Sanghera C J Nucl Med. 2020; 61(12):1743-1748.

PMID: 32513905 PMC: 8679631. DOI: 10.2967/jnumed.119.240598.


Functional imaging of hepatocellular carcinoma.

Hoogenboom T, Thursz M, Aboagye E, Sharma R Hepat Oncol. 2018; 3(2):137-153.

PMID: 30191034 PMC: 6095326. DOI: 10.2217/hep-2015-0005.


Evaluation of F-fluorothymidine positron emission tomography ([F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer.

Sharma R, Mapelli P, Hanna G, Goldin R, Power D, Al-Nahhas A EJNMMI Res. 2016; 6(1):81.

PMID: 27854031 PMC: 5112222. DOI: 10.1186/s13550-016-0234-3.


A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.

Kostakoglu L, Duan F, Idowu M, Jolles P, Bear H, Muzi M J Nucl Med. 2015; 56(11):1681-9.

PMID: 26359256 PMC: 4737647. DOI: 10.2967/jnumed.115.160663.